Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Merck charged in France over failure to inform on changes to thyroid drug

The French unit of German pharmaceuticals firm Merck has been charged with willful commercial deception for failing to inform patients of changes to a thyroid treatment that could result in serious side-effects.

Radio France Internationale · Oct 20, 2022

Covid strain dubbed 'Nightmare Variant' doubled cases in days by 'beating immunity'

An infectious disease expert has said XBB is one of a 'slew' of fast-spreading variants.

Daily Record · Oct 20, 2022

Lisa Jarvis: New COVID variants have arrived. How worried should you be?

Some rather alarming headlines recently circulated about the newest members of the omicron family. “Nightmare COVID variant,” read one. “The most immune-evasive COVID variants yet.” Or, as one would-be pandemic influencer said in a tweet shared thousands of times: “MOTHER OF GOD… #COVID variants worse than CDC has been admitting.”

Tribune News Service · Oct 20, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Indonesia bans syrup drugs after deadly kidney cases

JAKARTA: Indonesia has halted sales of medicinal syrup after 99 children died of acute kidney injuries this year.

Bangkok Post · Oct 20, 2022

Scientists engineer strain of Covid-19 with 80% kill rate

The researchers spliced elements of one of the newest strains onto a sample of one of the first types of Covid detected

Wales Online · Oct 20, 2022

Mum given overdose of paracetamol while being in treated for sickness and pneumonia - she died two weeks later

Laura Higginson died two weeks after the overdose - but the Crown Prosecution Service found it did not contribute to her death

Manchester Evening News · Oct 20, 2022

Under-reporting, stigmatisation makes chroming harder to tackle, experts tell Bradley Hope inquest

A coronial inquest has heard 13 per cent of almost 20,000 high-schoolers had tried chroming — but the full extent of the "incredibly difficult issue" is still not known.

ABC News · Oct 20, 2022

Read news from The Economist, FT, and more,
with one subscription

New Covid strain dubbed Nightmare Variant doubles cases in a day

The variant formally known as XBB has been detected in more than 17 countries so far

Wales Online · Oct 20, 2022

Zimbabwe becomes first African nation to approve HIV prevention drug

World Health Organization welcomes country’s ‘crucial step’ in backing use of long-acting injectable cabotegravir (CAB-LA)

The Guardian - UK · Oct 20, 2022

Leeds is monkeypox virus hotspot as new cases soar

Cases have been slowing down across the country, except in Leeds

Leeds Live · Oct 20, 2022

Chinese capital steps up COVID measures as cases quadruple

China's capital, Beijing, has dialled up measures to stop COVID, strengthening public checks and locking down some residential compounds after a quadrupling of its case load in recent weeks, just as a key Communist Party congress entered full swing.

Reuters · Oct 20, 2022

Indonesia finds medicines with ingredients linked to fatal child kidney injury

Some medicinal syrups available in Indonesia contained ingredients linked to fatal acute kidney injury (AKI) in children, its health minister said on Thursday, as it investigates a spike in cases and 99 child deaths this year.

Reuters · Oct 20, 2022

An entirely new illicit drug has been discovered by Australian chemists. Here's how they did it

Imagine, if you will, a small plastic baggy containing a mixture of crystals and powder.

The Conversation · Oct 20, 2022

As hepatitis C proliferates, states lift barriers to treatment

While national efforts to eliminate hepatitis C have faced setbacks because of increased drug use, the impact of COVID-19 and insurance complications, there’s a bright spot: Some states are now making it easier for patients to treat the disease.

Tribune News Service · Oct 19, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service · Oct 19, 2022

Abbott plans a new $500M baby-formula plant to increase U.S. capacity for the vital product

Abbott Laboratories is building a new infant-formula manufacturing plant after the product shortage of the past year revealed gaps in U.S. production capacity.

The Independent UK · Oct 19, 2022

US clears Novavax COVID booster dose

The Food and Drug Administration has authorized a booster dose of the COVID-19 vaccine made by Novavax

Chicago Sun-Times · Oct 19, 2022

Criminalizing drug use won’t help stop addiction

Drug addicts need treatment, as Peter Bensinger rightfully pointed out, but he is badly mistaken to think that the criminalization of drug sales and possession are also deterrents.

StockNews.com · Oct 19, 2022

This Pharmaceutical Stock Is Still a Smart Buy in 2022

Pfizer’s (PFE) co-developed COVID-19 vaccine booster for children, which recently got Emergency Use Authorization from the U.S. FDA, could boost its share price. The stock had witnessed significant attention during the pandemic and could still be worth owning. Let’s discuss this in detail….

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Oct 19, 2022

Engineering Psychedelics: $22M Pool For Clinical Trials Of Compounds Targeting CNS Disorders

NYC and Cambridge-based Empyrean Neuroscience Inc. is a new genetic engineering company developing neuroactive compounds for neuropsychiatric and neurological disorders launching with a $22 million Series A financing.

Benzinga · Oct 19, 2022

The Perils Of Delta-8 THC And Other 'Hemp' Products That Get You High: Why Unregulated Intoxicating Hemp Products Can Be Dangerous

The California Cannabis Industry Association (CCIA), a trade group representing hundreds of companies participating in the United States’ largest regulated cannabis market, has released a white paper entitled “Pandora’s Box: The Dangers of a National, Unregulated, Hemp-Derived Intoxicating Cannabinoid Market.&

The Philadelphia Inquirer · Oct 19, 2022

FDA panel advises taking preterm birth drug off the market

An FDA advisory panel voted 14-1 on Wednesday to recommend that the agency withdraw its approval of the drug Makena, saying the treatment does not appear to reduce the risk of preterm birth.

StockNews.com · Oct 19, 2022

2 Biotech Stocks to Take off Your Watchlist in 2022

Amid the macroeconomic issues and rampant volatility in the market, investor sentiment toward biotech stocks is declining. Many companies in this space are planning layoffs to reduce expenses. Amid the grim backdrop, we think investors should drop fundamentally weak biotech stocks Ginkgo Bioworks Holdings (DNA) and Immunic (IMUX) from their…

Chronicle Live · Oct 19, 2022

Eligible residents urged to get vaccinated as Covid cases rise

There are fears of a "twindemic" of Covid and flu this winter

The Guardian - UK · Oct 19, 2022

WHO forced to ration vaccine as cholera cases surge worldwide

Health officials halve dose to eke out ‘extremely limited’ supply amid unprecedented rise in outbreaks

Axios · Oct 19, 2022

FDA panel votes to remove early pregnancy drug from market

The Makena drug is the only one of its kind in the U.S.

1 … 118 119 120 121

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Crown Prosecution Service

653 stories

Food and Drug Administration

583 stories

Australian National University

Northumberland County Council

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.